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With increasingly large numbers of mouse models of human disease dedicated to MRI
studies, compromises between in vivo and ex vivo MRI must be fully understood in
order to inform the choice of imaging methodology. We investigate the application of
high resolution in vivo and ex vivo MRI, in combination with tensor-based morphometry
(TBM), to uncover morphological differences in the rTg4510 mouse model of tauopathy.
The rTg4510 mouse also offers a novel paradigm by which the overexpression of
mutant tau can be regulated by the administration of doxycycline, providing us with a
platform onwhich to investigatemore subtle alterations inmorphology withmorphometry.
Both in vivo and ex vivo MRI allowed the detection of widespread bilateral patterns of
atrophy in the rTg4510 mouse brain relative to wild-type controls. Regions of volume
loss aligned with neuronal loss and pathological tau accumulation demonstrated by
immunohistochemistry. When we sought to investigate more subtle structural alterations
in the rTg4510 mice relative to a subset of doxycycline-treated rTg4510 mice, ex vivo
imaging enabled the detection of more regions of morphological brain changes. The
disadvantages of ex vivo MRI may however mitigate this increase in sensitivity: we
observed a 10% global shrinkage in brain volume of the post-mortem tissues due
to formalin fixation, which was most notable in the cerebellum and olfactory bulbs.
However, many central brain regions were not adversely affected by the fixation protocol,
perhaps due to our “in-skull” preparation. The disparity between our TBM findings from
in vivo and ex vivo MRI underlines the importance of appropriate study design, given
the trade-off between these two imaging approaches. We support the utility of in vivo
MRI for morphological phenotyping of mouse models of disease; however, for subtler
phenotypes, ex vivo offers enhanced sensitivity to discrete morphological changes.
Keywords: MRI imaging, preclinical imaging, in vivo imaging, phenotyping, tensor-basedmorphometry, tauopathy,
mouse models, neurodegeneration
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INTRODUCTION
Since Nature published the initial sequence of the (Mouse
Genome Sequencing Consortium et al., 2002), there has been a
marked increase in the number of transgenic and gene-targeted
mice that have been engineered to deepen our understanding of
the function of genes in human biology. It has been estimated
that to create a knock-out mouse for each of the 20,000 genes
in the mouse genome, over 7 million animals will be required
in order to fully characterize the subsequent loss of gene activity
(Qiu, 2006). This figure does not include knock-in and transgenic
mice, all of which will also require characterization in order to
fully comprehend gene function.
In order to analyse complex phenotypes, robust and
reproducible methods for phenotyping are required (Gates
et al., 2011). Biochemical, behavioral, anatomical, physiological
and pathological assays all contribute to understanding the
true function of a gene (Crawley, 2008). Phenotyping, at the
macroscopic and microscopic level, is traditionally carried out
using histological methods, which are useful for validating
hypotheses and uncovering unexpected biochemical changes
that accompany altered gene function. However, preparation
of the tissues for histological analysis is terminal, invasive and
limited by low throughput. Recently, techniques for structural
phenotyping have moved beyond the use of histology to embrace
whole-organ or organism, high resolution imaging methods
(Turnbull and Mori, 2007; Lau et al., 2008; Carroll et al., 2011;
Cleary et al., 2011a,b; Lerch et al., 2011a; Yu et al., 2011; Badhwar
et al., 2013; Ellegood et al., 2013; Norris et al.).
Magnetic resonance imaging (MRI) is a powerful, non-
invasive imaging technology which is increasingly employed
for phenotyping transgenic mice; this is largely due to
advances in MRI hardware and computer power, which facilitate
the application of sophisticated image processing techniques
(Benveniste and Blackband, 2002; Ma et al., 2005, 2008, 2014;
McConville et al., 2005; Lau et al., 2008; Lerch et al., 2008a,b,
2011b; Spring et al., 2010; Zhang et al., 2010; Badhwar et al., 2013;
Hébert et al., 2013). Through a combination of high resolution
MRI and automated computational analysis, the throughput
and efficiency of structural phenotyping of transgenic mice will
significantly improve.
One of the key experimental decisions when scanning amouse
brain for phenotypic changes is whether to image the animal
alive or dead in order to maximize sensitivity to morphological
alterations with respect to wild-type (WT) controls (Lerch et al.,
2012). Post-mortem imaging enables longer scan times, the use
of contrast agents in high concentrations and limits motion.
These factors can boost resolution, signal-to-noise ratio (SNR)
and contrast-to-noise ratio (CNR) to support advanced, unbiased
computational approaches such as tensor-based morphometry
(TBM) (Lerch et al., 2008b; Ma et al., 2014). In addition,
multiple brains can be imaged simultaneously using standard
MRI hardware, thereby improving the throughput of data
acquisition (Bock et al., 2005). Conversely, live animals’ tissues
do not suffer distortions and dehydration from fixation, which
may disrupt their integrity (Cahill et al., 2012). Crucially, in vivo
imaging permits longitudinal studies, where the same animal
can be serially assessed to observe morphological and functional
changes over time (Lau et al., 2008; Zhang et al., 2010). This has
been shown to improve the statistical power of results (Lerch
et al., 2012) as well as reduce the number of animals required for
imaging studies, compared to cross-sectional studies.
In this study, we sought to expand upon our previous findings
(Lerch et al., 2012), by investigating the sensitivity of in vivo
and ex vivo MRI to morphological differences occurring in the
rTg4510 mouse model of tauopathy (SantaCruz et al., 2005). The
rTg4510 mouse exhibits gross atrophy of the forebrain regions,
and has been extensively characterized in previous in vivo MRI
studies (Yang et al., 2011; Wells et al., 2015; Holmes et al.,
2016). Furthermore, the rTg4510 mouse offers a novel paradigm
to support our investigation, as the overexpression of tau can
be inactivated by the administration of doxycycline (SantaCruz
et al., 2005). Therefore, in addition to characterizing the gross
morphological differences between the transgenic and WT
animals, we also sought to identify the sensitivity of in vivo and
ex vivoMRI to the more subtle structural changes occurring in a
subset of doxycycline-treated rTg4510 mice, relative to untreated
rTg4510 mice. For morphological characterization, we employed
an automated TBM pipeline for high throughput analysis of
neuroanatomy in the mouse brain (Powell et al., 2016). TBM
has previously been applied to a number of clinical disorders,
including epilepsy (Keller and Roberts, 2008) and Alzheimer’s
disease (Fox et al., 1996, 2001; Hua et al., 2008). Its advantages
include the ability to sensitively highlight structural differences
between groups without specifying a region of interest (ROI). The
technique is increasingly employed in high throughput mouse
structural phenotyping studies (Lau et al., 2008; Lerch et al.,
2008b; Zhang et al., 2010).
In this work, we sought to directly compare parameters which
must be considered when phenotyping transgenic mice using
either in vivo or ex vivo MRI. We investigated differences in
image quality; the effect of formalin-fixation on post-mortem
tissue structure; distortions due to the ex vivo tissue preparation
protocol; the sensitivity of TBM to morphological changes
occurring in the rTg4510 mice, scanned both in vivo and ex vivo;
and the relative effect sizes detected by each paradigm.
MATERIALS AND METHODS
Transgenic Animals
Generation of homozygous rTg4510 transgenic mice has been
reported previously (SantaCruz et al., 2005). rTg4510 mice were
licensed from the Mayo Clinic (Jacksonville Florida, USA) and
bred for Eli Lilly by Taconic (Germantown, USA). Mice were
imported to the UK for imaging at the Centre for Advanced
Biomedical Imaging, UCL, London. All studies were carried out
in accordance with the United Kingdom’s Animals (Scientific
Procedures) Act of 1986 and approved by the UCL internal ethics
committee.
In this study, 8 female WT and 17 female rTg4510 litter-
matched control mice were imaged both in vivo and ex vivo
at 7.5 months of age. Of the 17 rTg4510 animals, 7 were fed
with doxycycline mixed chow from 4.5 months to suppress the
overexpression of tau.
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Magnetic Resonance Imaging
All imaging was performed using a 9.4T VNMRS horizontal bore
scanner (Agilent Inc.). The key differences between the in vivo
and ex vivo protocols are outlined in Table 1. For in vivo imaging,
mice were anesthetized under 2% isoflurane and positioned in
an MRI compatible head holder to minimize motion artifacts.
Anesthesia was then maintained at 1.5% isoflurane in 100%
O2 throughout imaging. Core temperature and respiration were
monitored using a rectal probe and pressure pad respectively
(SA instruments). Mice were maintained at ∼37◦C using heated
water tubing and a warm air blower with a feedback system (SA
Instruments).
In vivo Structural Imaging
A 120 mm diameter imaging gradient set (SGRAD
205/120/HD/S, Agilent Technologies UK Ltd., Berkshire,
UK) was used. A 72 mm birdcage radiofrequency (RF) coil
was employed for RF transmission and a quadrature mouse
brain surface coil (RAPID, Germany) was used for signal
detection. Tuning and matching of the coil was performed
manually.
A T2-weighted, three dimensional (3D) fast spin echo (FSE)
sequence was implemented for structural imaging with the
following parameters: Field-of-view (FOV) = 19.2 × 16.8 ×
12.0 mm; resolution = 150 × 150 × 150µm; repetition time
(TR) = 2,500 ms, effective echo time (TEeff) = 43 ms, ETL = 4;
NSA= 1. Total imaging time was∼1 h and 30 min.
Perfusion Fixation
Following in vivo imaging, animals were terminally anesthetized
with an overdose of Euthanal administered via intraperitoneal
injection. The thoracic cavities were opened and the animals were
intracardially perfused through the left ventricle of the heart:
first with 15–20 mL of saline (0.9%) and heparin; second with
50 mL of Formalin and 8 mM Magnevist, at a flow rate of 3
mL per minute. Following perfusion, the animal was decapitated,
defleshed, and the lower jaw removed. All brains were stored
in-skull at 4◦C and soaked in Formalin doped with 8 mM
Magnevist R© for 9 weeks prior to ex vivo scanning (Cleary et al.,
2011b).
TABLE 1 | Summary of the key differences between in vivo and ex vivo
scanning protocols.
In vivo Ex vivo
Sequence Fast spin echo Gradient echo
Weighting T2-weighted T2*-weighted
Resolution 150µm3 40µm3
Imaging time 1 h 30 min 11 h 24 min
Imaging coil 4 channel surface coil Volume coil
No. of subjects imaged per acquisition 1 3
Averages 1 6
Contrast agent? N Y
Ex vivo Structural Imaging
An imaging gradient set with a 60 mm inner diameter (SGRAD
115/60/HD/S, Agilent Technologies UK Ltd., Berkshire, UK)
was used. A 35 mm birdcage RF coil was employed for RF
transmission and signal detection. Tuning and matching of the
coil was performed manually.
A custom-build three brain holder was used to acquire high
resolution ex vivo images of multiple brains simultaneously. A
3D gradient echo (GE) sequence was implemented for structural
imaging with the following parameters: FOV = 32 × 25 × 25
mm; resolution= 40× 40× 40µm; TR= 17 ms; TE = 4.54 ms;
flip angle = 51◦; NSA = 6. Total imaging time was 11 h 36 min
(Cleary et al., 2011b).
Following ex vivo scanning, all brains were dispatched for
histology.
Image Processing
In vivo and ex vivoMR images were reconstructed using custom
software written in MATLAB. A previously published calibration
protocol (O’Callaghan et al., 2014) was used to adjust volume
estimates to correct for scaling errors caused by the imaging
gradients. Briefly, a 3D grid phantom was imaged in both
gradient sets and CT data was used as a ground truth to generate
absolute scaling factors that were then applied to the data.
Tensor-Based Morphometry
TBM was performed on in vivo and ex vivo structural images
using a fully-automated pipeline (Powell et al., 2016). Images
were automatically oriented to a standard space (Right Antero-
Superior) matching that of an atlas, corrected for intensity non-
uniformity using the N4 algorithm (Tustison et al., 2010), and
skull stripped using STEPS (Cardoso et al., 2013) to combine
masks from several prior atlas images non-rigidly registered to
the data. To mask our in vivo and ex vivo data, we used in vivo
and ex vivo atlases published by Ma et al. (2005, 2008).
The total brain volume (TBV) was calculated from the
resulting brain mask for each individual image. For in vivo
and ex vivo groups, using the voxels within each mask, brain
intensities were standardized using a piece-wise linear method
described by Nyul et al. (2000). A multi-iteration group-wise
registration (implemented in the open-source NiftyReg software
package available from https://sourceforge.net/projects/niftyreg,
Modat et al., 2010) was performed as follows to align equivalent
local regions between subjects. First, all subjects were rigidly
aligned to a randomly-chosen target member of the group. This
was followed by four iterations of global affine registration (12
degrees of freedom) between subjects and the target image,
using a block-matching algorithm (Modat et al., 2014) with
normalized cross-correlation used as the similarity metric. After
each iteration of registration, the group intensity average of
all the transformed, resampled images was found in the space
of the target, and was used as the target for the subsequent
iteration of registration. Next, we performed 20 iterations of
non-rigid registration (NRR), based upon symmetric free-form
deformation (Modat et al., 2012). Control points were spaced at
4 voxel intervals and the similarity measure used was normalized
mutual information. As the iterations progressed, the average
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image sharpened as alignment improved and approached the true
average morphology of the group.
We transformed the deformation fields from this registration
by taking the log of the determinant of the Jacobian matrix
calculated at each voxel in the final average image space, to
give that voxel’s relative expansion or contraction from the
final average image to each original image. These values were
smoothed with a 0.2 mm FWHM Gaussian kernel to account
for registration error and to render the values closer to a normal
distribution. This was chosen to enhance physical differences
between groups at approximately the same scale (the matched
filter effect; Ashburner and Friston, 2001). We used the same
FWHM for both in vivo and ex vivo data, so as to minimize
this step as a source of variation between the methods: we
did not expect the physical variation between groups to differ
between in vivo and ex vivo. We performed mass-univariate
statistics (two-tailed t-tests) at each voxel, fitting a General
Linear model to reveal the most significant voxels contributing to
global differences. The resulting statistical parametric maps were
corrected for multiple tests using the False Discovery Rate (FDR,
Genovese et al., 2002, q= 0.05).
Deformation Maps
To measure the degree of local variability between ex vivo
and in vivo images, we registered each ex vivo brain to its
corresponding in vivo counterpart, and calculated the mean
positional distance at each voxel after resampling the resulting
deformation fields into the in vivo brains’ average space
(Kovacˇevic´ et al., 2005). The magnitude of the 3D vectors was
calculated and the mean found over all N deformation fields, i:
MPD (voxel) =
1
N
N∑
i= 1
√
x2i + y
2
i + z
2
i
where x, y, z are the vector components from the non-
rigid registration only (excluding global rigid and affine
transformations).
Signal-to-Noise and Contrast-to-Noise
Ratio Calculations
SNR and CNR were calculated from WT mice (n = 3) using the
following formulae:
SNR =
Mean signal
Noise
CNR =
Mean signalcortex −Mean signalcorpus callosum
Noise
Signal was taken from the following ROIs: caudate
putamen, cerebellum, corpus callosum, cortex, hippocampus,
hypothalamus, olfactory bulb, midbrain and thalamus. The
noise ROI was placed in a ghost-free region of background
signal. Noise was defined as the standard deviation of the
background signal. A 2-way ANOVA with post-hoc Sidak
multiple comparisons was used to identify significant differences
between SNR in the in vivo and ex vivo ROIs.
Effect Size and Sample Size Calculation
Each dataset may be treated as a preliminary study from which to
estimate the number of mice, N, (per group) required in a future
ex vivo or in vivo study to show meaningful differences between
the WT and untreated rTg4510 groups, with specified statistical
power. We chose a conventional significance level of α = 0.05, a
false negative rate β = 0.2, and initially assumed the WT group
provided a reasonable estimation of local structural variability
within the rTg4510 mouse population. To detect a 25% local
volume difference between WT and untreated rTg4510 groups
measured in Jdet values, at each voxel, the required number of
animals in each arm of the study is (Florey, 1993):
Narm =
2×
(
Zα/2 + Z1−β
)2
×WT2
stdev
(0.25)2
where Zα/2 = 1.96 is the approximate number of standard
deviations from the mean of a standard normal distribution of
1−(α/2) = 0.975; likewise, Z1−β = 0.84 for 1−β = 0.8.WTstdev
is the standard deviation of the WT Jdet values, from GWR, at
a particular voxel. These vary across the brain depending upon
local WT variability. Narm is rounded up to the nearest integer.
As the actual difference between mean UT andWT Jdet values
is known post-hoc, the effect sizes (Cohen’s d), both in vivo and
ex vivo, may be visualized and compared at each voxel. This helps
to quantify which regions are most different, between groups,
regardless of statistical significance:
Cohen’s d =
UTmean −WTmean
WTstdev
We calculated d using a pooled standard deviation, replacing
WTstdev with σpooled:
σpooled =
√(
WT2
stdev
× (NWT − 1)+ UT
2
stdev
× (NUT − 1)
)
NWT + NUT − 2
Figure 5 shows equivalent slices from the in vivo and ex vivo
group-wise average images, overlaid with the d andNarm required
at each voxel to detect a 25% variation in Jdet from theWTmean,
giving a realistic lower bound for future studies of the rTg4510
mouse.
Histology and Immunohistochemistry
Brain samples were processed using a Tissue TEK R© VIP
processor (GMI Inc, MN USA). After processing, sections were
embedded in paraffin wax to allow coronal brain sections to be
cut. Serial sections (6µm) were taken using HM 200 and HM
355 (Thermo Scientific Microm, Germany) rotary microtomes.
Immunohistochemistry (IHC) was performed using a primary
antibody for tau phosphorylated at serine 409 (PG-5; 1:800
from Peter Davies, Albert Einstein College of Medicine, NY,
USA) and the neuronal marker NeuN (1:500 from Millipore;
MAB377). Following de-paraffinisation and rehydration of the
tissue sections, antigen retrieval was performed using the Lab
Vision PT module system (Thermo Scientific), where sections
were heated to 100◦C for 20 min in citrate buffer (TA-250-PM1X;
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Thermo Scientific). Slides were transferred to a Lab Vision
Autostainer (Thermo Scientific) where the following incubations
were performed: 10 min in H2O2 (0.3%); 30 min in normal goat
serum (1:20; Vector Laboratories); 60 min in primary antibody;
30 min in biotinylated goat anti-mouse IgG (1:200, BA9200;
Vector Laboratories); 30 min avidin-biotin complex solution
(PK-7100; Vector Laboratories); 5 min in 3,3′-diaminobenzidine
(SK-4105; Vector Laboratories). Apart from the last two steps,
PBS with 0.05% Tween-20 (PBS-T) was used for diluting reagents
and washes between steps. Sections were then counterstained
with haematoxylin before dehydration and cover-slipping.
To quantify the density of PG-5 and NeuN positive neurons,
stained sections were digitized using the Scanscope AT slide
scanner (Aperio) at 20× magnification. Imagescope software
(version 11.1.2.780; Aperio) was used to view the digitized tissue
sections and delineate the boundaries of the cortex. PG-5 positive
cells were manually counted within the delineated region and
NeuN positive cells were quantified using a nuclear detection
algorithm (Imagescope, version 11.1.2.780; Aperio); both were
expressed as a percentage of the total area. These analyses
were performed in a blinded fashion. A one-way ANOVA with
post-hoc Tukey multiple comparison was performed to identify
significant differences between the groups.
RESULTS
Effect of In vivo and Ex vivo Scanning on
SNR and CNR
In order to explore image quality, we investigated quantitative
differences in SNR and CNR measurements from WT animals
(Table 2). The SNR and CNR measurements are representative
results from practical scan times achievable for the in vivo and
ex vivo imaging protocols (Table 2). This was 1.5 h in vivo, which
permitted the acquisition of other complementary functional
scans within a feasible in vivo imaging time (Holmes et al., 2016),
and 12 h to image 3 ex vivo brains simultaneously (4 h per ex vivo
specimen), which maximized the utility of the MRI scanner by
imaging overnight.
TABLE 2 | Mean (±SD) signal-to-noise ratio and contrast-to-noise ratio for
in vivo and ex vivo wild-type mouse brains.
Region SNR P-value
In vivo (n = 3) Ex vivo (n = 3)
Caudate putamen 14.4 ± 1.7 9.3 ± 1.1 ≤0.001
Cerebellum 7.6 ± 0.9 11.4 ± 0.6 ≤0.05
Corpus callosum 15.6 ± 0.6 4.2 ± 0.7 ≤0.0001
Cortex 14.2 ± 1.4 10.0 ± 0.8 ≤0.01
Hippocampus 19.3 ± 1.2 10.8 ± 0.8 ≤0.0001
Hypothalamus 11.2 ± 1.2 11.5 ± 0.7 ns
Olfactory bulb 14.8 ± 1.9 10.9 ± 1.1 ≤0.05
Midbrain 11.1 ± 1.2 6.9 ± 0.6 ≤0.01
Thalamus 12.4 ± 1.5 7.8 ± 1.0 ≤0.01
CNR (gray-white matter) 1.5 5.8 ≤0.01
We observed an increase in SNR of the in vivo images
compared to the ex vivo images in 7 of the 9 regions investigated:
the caudate putamen (55%), corpus callosum (271%), cortex
(42%), hippocampus (79%), olfactory bulb (36%), midbrain
(61%), and thalamus (59%). Meanwhile, the SNR ex vivo was
significantly greater in the cerebellum (50%). Conversely, we
observed a three-fold increase in CNR between gray matter
(cortex) and white matter (corpus callosum) structures in the
ex vivo images compared to in vivo (p ≤ 0.01).
It is important to note the differences in the in vivo and ex vivo
imaging protocols (detailed in Table 1) which will impact the
SNR and CNR values. For instance, SNR is highly dependent
on spatial resolution, and increases proportionally to the volume
increase of the voxel. The larger voxel size (150µm3 in vivo vs.
40µm3 ex vivo) of the in vivo acquisition will have been key
contributors to the increased SNR in vivo. Theoretically, if all
other imaging parameters were the same, this increase in voxel
size in vivo would result in an increase in SNR by a factor of∼ 53
when compared to ex vivo (Parker and Gullberg, 1990). However,
this estimation does not take into account other differences
between the imaging protocols: the use of a surface coil in vivo
will have contributed to increased SNR relative to the ex vivo
volume coil, whilst the high concentrations of contrast agent
employed ex vivowill have shortened the T1 relaxation properties
of the tissues and enabled the acquisition of high resolution 3D
scans with improved SNR.
Effect of Perfuse-Fixation on Brain
Structure: Comparison of In vivo and
Ex vivo
It has previously been reported that formalin fixation causes
tissue shrinkage (Siegel et al., 1985; Zhang et al., 2010; Lerch et al.,
2012) which may be a confounder in our ex vivo MRI protocol,
particularly if this shrinkage is inhomogeneous across structures.
In order to investigate the changes in brain morphometry
occurring due to formalin fixation, we extracted total brain
volumes (TBVs) for the in vivo and ex vivo mouse brain
specimens using a previously published multi-atlas segmentation
protocol (Ma et al., 2014). We observed a 10% reduction in
ex vivo TBV compared to in vivo (p ≤ 0.0001) (Figure 1 and
Supplementary Table 1). The degree of shrinkage was similar for
WT controls (10.3%), rTg4510 mice (10.4%) and doxycycline-
treated rTg4510 mice (10.1%), which suggest that the overall
extent of fixation-induced shrinkage is unrelated to tau pathology
in this model.
We also investigated the regional effects of perfuse-fixation
on brain structures by registering the ex vivo images to their
corresponding in vivomouse brain template, using methodology
previously described by Ma et al. (2008). The mean positional
distance map, showing mean intra-subject registration distances
between in vivo and ex vivo images pairs is shown in Figure 2.
The greatest changes were found within structures located
frontally (the olfactory bulbs) and caudally (the brainstem). In
these regions, displacements were greater than 0.25 mm can
be readily visualized. The brainstem was particularly vulnerable
to disturbance and exhibited displacements of up to 0.5 mm;
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FIGURE 1 | In vivo and ex vivo total brain volumes for wild-type,
rTg4510 and rTg4510 (+DOX) animals. In vivo vs. ex vivo comparisons:
****p ≤ 0.0001. In vivo TBV comparisons: ++p ≤ 0.01; ++++p ≤ 0.0001.
Ex vivo TBV comparisons: −−p ≤ 0.01; −−−−p ≤ 0.0001. Whiskers
represent the maximum and minimum values.
these can be attributed to the fixation protocol which requires
decapitation of the mouse. We also observed displacements
within the rostral aspect of the olfactory bulbs, however the
distances are markedly less than previous findings within this
structure (Kovacˇevic´ et al., 2005; Ma et al., 2008). The remaining
brain structures, including themidbrain, hippocampus, thalamus
and cortex, were relatively unaffected by perfuse-fixation. It is
noticeable that the cortical surface also showed very few signs of
systematic perturbation associated with the ex vivo protocol.
Effect of Tau Pathology on Brain Structure:
Comparison of In vivo and Ex vivo
We observed that the rTg4510 mice had markedly smaller brains
when compared to WT (p≤ 0.0001) and the doxycycline-treated
rTg4510 mice (p ≤ 0.01) (Figure 1 and Supplementary Table 1)
from both in vivo and ex vivo measurements. Importantly, the
total volume differences were consistent between the in vivo and
ex vivo TBV measurements: rTg4510 mice were 21% smaller
that WT controls, and 16% smaller than the doxycycline-treated
rTg4510 mice for both the in vivo and ex vivo cohorts.
Tensor-Based Morphometry
Comparison between rTg4510 Mice and Wild-Type
Controls
The in vivo TBM results identified extensive bilateral atrophy
within the forebrain regions, including the cortex, caudate
putamen, hippocampus and hypothalamus, as well as expansion
of the lateral, third and fourth ventricles (Figure 3A). Regions
of expansion were also observed within the cerebellum
(Figure 3Avii). A similar pattern of atrophy was also observed
ex vivo, although these alterations appear to be more widespread
in comparison to the in vivo findings (Figure 3B).
Comparison between rTg4510 Mice and
Doxycycline-Treated rTg4510 Mice
In order to investigate the sensitivity of in vivo and ex vivo
imaging to subtler structural changes, we sought to identify
morphological differences between the genetically identical
doxycycline-treated and untreated rTg4510 mice (Figure 4).
Due to the smaller morphological differences between
the doxycycline-treated and untreated rTg4510 mice (Holmes
et al., 2016), we observed correspondingly reduced regions
of expansion and contraction in the in vivo and ex vivo
brains (Figure 4), in contrast to the comparison of rTg4510
mice to WT controls detailed in Figure 3. The ex vivo results
appear more sensitive in this case, and identified a relatively
widespread pattern of morphometric changes, with volume loss
detected in the cortex, caudate putamen and caudal hippocampal
regions (Figure 4B). The in vivo results identified small discrete
clusters of significant voxels within the piriform area of the
cortex (Figure 4Aii) and caudal slices of the hippocampus
(Figure 4Aiv). Although the in vivo findings were not as spatially
extensive, we observed good regional correspondence between
the TBM results observed in vivo and those identified ex vivo,
with significant voxels identified in many of the same regions.
Effect Size and Sample Size
To inform future studies in the rTg4510 mouse, we calculated
Cohen’s d andNarm for the comparison of rTg4510 mice andWT
controls (Figure 5). The map of Cohen’s d, in measuring group
mean separation, is similar to the thresholded statistical maps
in Figure 3. The separation of groups in the hippocampus and
cortex is greater ex vivo.
The Narm analysis broadly identified that a small sample size
of under 10 subjects would be sufficient to detect statistically
significant differences between the WT and rTg4510 groups by
performing TBM in the ex vivo data, across the majority of brain
structures, including the midbrain and cerebellum. In order to
recover structural changes occurring in vivo, a sample size of
around 15 is required in order to ensure statistical significance
of changes occurring in the cortex and forebrain regions. Narm
was elevated around the ventricles both in vivo and ex vivo (Narm
>18) although this observation was most marked in vivo. The
Narm was also elevated in the entorhinal cortex of the in vivo data
(Narm >15), suggesting that a greater sample size is required
to recover changes within this structure; this is likely both due
to reduced WT ventricle volumes and increased WT variance
around these structures. Despite these observations, we were able
to recover structural changes occurring in both of these regions
in vivo with a reduced sample size (10 rTg4510 mice and 8 WT
controls), suggesting the volume changes were greater than 25%
of the WT volume.
Immunohistochemistry: Cortical PG-5 and
NeuN Density
In order to corroborate the MRI findings with
alterations occurring at the cellular level, quantitative
immunohistochemistry was performed on each of the individual
WT (n = 8), untreated rTg4510 (n = 10) and treated rTg4510 (n
= 7) mice following ex vivo imaging.
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FIGURE 2 | Mean positional distance maps showing local distortions of the ex vivo mouse brains in comparison to their in vivo mouse brain template.
Deformations were calculated at a voxel-wise level. The color bar illustrates the mean distance traveled by a voxel during registration of the ex vivo mouse brains to the
in vivo atlas.
The distribution of NeuN positive cells can be observed in
Figure 6A. The untreated rTg4510 mice showed a significant
decrease in the density of NeuN positive cells in the cortex
(mean NeuN density = 1,099 ± 107 cell/mm2) compared to
WT mice (mean NeuN density = 1,253 ± 131 cell/mm2)
(p ≤ 0.05) (Figure 6B). These results are consistent with
previous findings, and indicate marked neurodegeneration
in this model (SantaCruz et al., 2005; Wells et al., 2015).
Following treatment with doxycycline, we observed a significant
increase in NeuN density in the treated rTg4510 mice
(mean NeuN density = 1,301 ± 44 cell/mm2) compared
to the untreated rTg4510 mice (p ≤ 0.01) (Figure 6B).
No significant differences were observed between NeuN cell
densities in the treated rTg4510 mice compared to WT
mice.
Figure 6C shows the regional distribution of PG-5 positive
cells in a representative untreated rTg4510 mouse. In agreement
with previous findings in this model, we observed high levels
of PG-5 positive cells in the cortex of the untreated rTg4510
mice (mean PG-5 density = 369 ± 39 cell/mm2) (Figures 6C,D)
(Wells et al., 2015; Holmes et al., 2016). No PG-5 positive cells
were observed in theWTmice (Figure 6D). Following treatment
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FIGURE 3 | TBM results for the morphological comparison between rTg4510 mice and wild-type controls. Results from (A) in vivo and (B) ex vivo structural
analysis, showing TBM statistical results overlaid on representative axial and coronal slices of the final group average image after 20 iterations of NRR. Red: regions
where the rTg4510 brains are relatively locally smaller than the wild-type controls; blue: rTg4510 brains are locally larger. Based upon FDR-corrected t-statistics (q =
0.05).
with doxycycline, we observed a significant decrease in PG-5
positive cell density in the treated rTg4510 mice (mean PG-5
density = 268 ± 39 cell/mm2) compared to untreated rTg4510
mice (p ≤ 0.001) (Figure 6D).
DISCUSSION
With increasing numbers of rodent neuroimaging studies
employing TBM to identify regions of structural change (Lerch
et al., 2011a), it is important that the compromises between
in vivo and ex vivo MRI are fully understood in order to
maximize sensitivity to morphological differences. A number of
publications have previously addressed the trade-offs associated
with imaging in vivo and ex vivo mouse brains (Ma et al.,
2008; Scheenstra et al., 2009; Lerch et al., 2012); in this work,
we present the first application of TBM to both in vivo and
ex vivo structural MRI for investigating morphological changes
in a mouse model of disease: the rTg4510 model of tauopathy.
In addition to characterizing the gross morphological differences
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FIGURE 4 | TBM results for the morphological comparison between rTg4510 mice and doxycyline-treated rTg4510 mice. Results from (A) in vivo and (B)
ex vivo structural analysis, showing TBM statistical results overlaid on representative axial and coronal slices of the final group average image after 20 iterations of
NRR. Red: regions where the rTg4510 brains are relatively locally smaller than the treated rTg4510 brains; blue: rTg4510 brains are locally larger. Based upon
FDR-corrected t-statistics (q = 0.05).
in the rTg4510 mice compared to WT controls, the ability to
modulate the expression of the tau transgene with doxycycline
introduced subtler group differences in brain morphology to
explore using in vivo and ex vivoMRI. Both were able to capture
the gross atrophy occurring in the rTg4510 mice relative to WT
controls, with regions highlighted by TBM aligning with post-
mortem evaluation of tau pathology in this model. However,
when we sought to explore the more discrete alterations in a
subset of doxycycline-treated rTg4510 mice, the ex vivo findings
were more sensitive to regions of change. A number of different
factors will affect the ability of in vivo and ex vivo MRI to detect
morphological changes. This discussion explores some of these
in more detail, and highlights the major differences that must be
considered for future neurological studies of mouse models.
Our T2-weighted in vivo MRI images enabled visual
identification of many structures of interest in the mouse brain,
including the hippocampus, caudate putamen and cortex. This
was achieved in the absence of exogenous contrast agents,
such as manganese, which are frequently employed in in vivo
studies of mouse neuroanatomy (Koretsky and Silva, 2004; Yu
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FIGURE 5 | Power analysis results in rTg4510 data compared with wild-type: Cohen’s d and sample sizes. Equivalent sagittal, coronal and transverse slices
on in vivo and ex vivo GWR average images, overlaid with the Cohen’s d (left) and sample sizes N (right) required to show a significant effect, with α = 0.05, β = 0.2,
and an effect size 25% of the local wild-type mean volume. For Cohen’s d: red, rTg4510 group locally smaller than wild-type; blue: larger.
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FIGURE 6 | Immunohistochemistry to estimate cortical NeuN and PG-5 positive cell density. Representative coronal slice illustrating the distribution of
(A) NeuN and (C) PG-5 positive neurons in the cortex of an untreated rTg4510 mouse. Quantitative estimates of (B) NeuN and (D) PG-5 positive cell density in the
cortex for each of the 7 wild-type, 10 untreated rTg4510 and 6 treated rTg4510 mice at 7.5 months of age. Whiskers represent the maximum and minimum values.
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001.
et al., 2005). High doses of manganese are believed to produce
neurotoxic effects (Thuen et al., 2008; Pan et al., 2011), which
could confound longitudinal analysis by interfering with both
normal healthy aging and disease progression. In this work,
we instead exploited the inherent differences in T1 and T2
relaxation time to achieve adequate in vivo image contrast.
Conversely, high resolution ex vivo MR images were acquired
using a previously optimized protocol which employed the
gadolinium-containing contrast agent Magnevist (Cleary et al.,
2011b); the T1-shortening effects of gadolinium enabled the
acquisition of high resolution 3D data sets within a feasible scan
time (typically overnight, to maximize the efficiency of scanner
usage). The protocol was adapted to permit the acquisition of
three ex vivo mouse brains simultaneously, which improved
throughput and minimized the required operator time per
brain.
SNR and CNR measurements of the in vivo and ex vivo data
sets allowed a quantitative assessment of image quality to support
our investigation. Despite limits on scan time, the increasing
availability of specialist hardware to support in vivo imaging
studies permits the acquisition of in vivo data with sufficient
SNR and CNR to perform informative voxel wise analyses of
mouse brain morphometry. Natt et al. previously reported that
SNR of 15 – 20 was sufficient to reveal anatomical details in the
in vivomouse brain (Natt et al., 2002); in our measurements, the
majority of in vivo brain structures under investigation fell within
these proposed boundaries.
Another important consideration when imaging ex vivo tissue
specimens is the effect of formalin-fixation on tissue integrity.
It has previously been reported that fixation of ex vivo brain
specimens results in dehydration and subsequent reduction of
the relative proton density of tissues (Shepherd et al., 2009).
This can cause a reduction in SNR in ex vivo images, although
increasing the number of signal averages helped to mitigate this
effect (Liu et al., 2013). Despite the lower SNR, ex vivo MRI
had greater gray-white matter contrast compared to the in vivo
images; this enhancement in CNR can largely be explained by
the use of the contrast agent (Kim et al., 2009). We propose that
CNRmay be amore importantmeasure of image quality for TBM
investigations, particularly when the similarity measure which
drives the image registration algorithm depends upon contrast
(we used normalized mutual information, with NiftyReg).
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It is important to note that the differences in the in vivo
and ex vivo imaging protocols will all have contributed to the
differences in SNR and CNR, making it difficult to untangle and
isolate an overriding factor that is influencing these values. An
alternative approach for this study would have been to implement
identical imaging protocols, thus eliminating the effects of
hardware, sample preparation and sequence optimization on
these quantitative measurements of image quality. However,
given the trade-offs associated with both approaches, we believed
this study was better executed by applying protocols which had
been individually optimized to meet the unique demands of
in vivo and ex vivo scanning.
Tissue shrinkage associated with formalin fixation is a widely
accepted occurrence, yet the extent to which brain tissues suffer
differential distortion is not fully known. A previous study
identified 4.37% shrinkage in post-mortem WT mouse brains
prepared for ex vivo MRI (Zhang et al., 2010), markedly less
than our observation of 10.3%. This discrepancy may be due to
differences in the fixation procedure, such as time spent in fixative
and the use of contrast agents. The authors also did not specify
whether a gradient calibration protocol was in place to estimate
gradient scaling errors of the different imaging systems used for
the acquisition of the in vivo and ex vivo data. An additional
study reported no significant difference between in vivo and
ex vivo total brain volumes in a cohort of Wistar rats (Oguz
et al., 2013); however, this work was also published without
specifying whether a calibration protocol was employed, and no
details of the fixation procedure were provided. In both cases,
if discrepancies between the respective gradient sets were not
accounted for, this may cause inaccuracies in the estimation of
ex vivo tissue shrinkage (O’Callaghan et al., 2014).
The mean positional displacement maps illustrating
distortions in the ex vivo specimens (Figure 2) provided
additional insight into the effects of the ex vivo preparation
protocol. We identified minimum disruption to the cortical
and central structures of the ex vivo mouse brain; these regions
were of particular interest in this mouse model, as atrophy
is most noticeable in the cortex and hippocampus due to the
regional distribution of tau pathology (SantaCruz et al., 2005).
The brain stem, meanwhile, suffered the greatest deformations
as it is not protected from disturbance by the skull. A previous
study identified similar disruption to the brain stem using
a voxel-wise analysis (Ma et al., 2008); however, the authors
reported additional disturbances in the dorsal cortical regions.
These brains were removed from the skull prior to ex vivo
imaging (Ma et al., 2005) which is likely to have caused damage
to the surface structures and subsequent local deformations. The
olfactory bulb, cortex and cerebellum are particularly vulnerable
to damage when extracting brains from the skull (Scheenstra
et al., 2009; Sawiak et al., 2012). We scanned brains in-skull, in
order to preserve cortical structures and alleviate any further
risks associated with the removal of brains from the skull. Despite
this methodical advantage, there were still some deformations
in the posterior structures, which may be due to the presence of
highly variable material outside the skull, which influences the
registration and which must be taken into consideration when
studying rodent models with an anticipated defect within these
regions.
When investigating morphological differences between the
rTg4510 and WT mice, we observed a similar bilateral pattern of
atrophy in the in vivo and ex vivo images using TBM.Many of the
same regions were identified as suffering volume loss, including
the frontal cortical regions and caudal slices of the hippocampus.
These regions are selectively vulnerable to neurofibrillary tangles
of tau and neuronal loss in this model (SantaCruz et al., 2005),
as depicted by the immunohistochemistry results. Conversely,
expansion was detected within the lateral, third and fourth
ventricles. Ventricular expansion, or “ventriculomegaly” has
previously been observed within AD patients in response to brain
shrinkage (Apostolova et al., 2012). Interestingly, expansion of
the ventricles was underestimated in the ex vivo images, owing to
collapse of the ventricular space during formalin fixation.We also
detected expansion within the cerebellum, a structure where we
did not anticipate anymorphological alterations. The unexpected
hypertrophy may be due to compensatory neuroplastic
mechanisms in response to the hippocampal volume loss, as
the cerebellum has recently been identified as a key structure in
spatial memory processing. Although both in vivo and ex vivo
data sets revealed comparable morphological changes, our
findings weremore spatially extensive ex vivo.The power analysis
results suggest that increasing the sample size may have enabled
a more widespread pattern of atrophy to be detected in vivo.
When TBM was used to investigate subtler structural changes
occurring in a cohort of doxycycline-treated rTg4510 mice,
relative to untreated rTg4510 mice, the benefits of ex vivo
MRI became more apparent. A more extensive bilateral pattern
of atrophy in the untreated vs. treated rTg4510 mice was
detected in the ex vivo data sets, which could be localized to
sub-regional structures such as the CA1 hippocampal subfield.
Previous work in this model has found that CA1 neuron numbers
stabilize following doxycycline treatment (SantaCruz et al., 2005),
a finding which may have manifested as a volume loss in
the untreated rTg4510 mice compared to those treated with
doxycycline. The increased CNR of the ex vivo data sets appeared
to benefit voxel-wise tests, enabling TBM to highlight more
extensive regions of difference between the groups. In addition,
the higher resolution afforded by ex vivoMRI permits improved
localization of volume changes to specific sub-regional structures.
These findings suggest the increased sensitivity of ex vivo imaging
for detecting subtle structural alterations, which may be an
important consideration for future neuroimaging studies in
mouse models which exhibit subtle morphological alterations.
Meanwhile, the in vivo TBM results for the untreated
vs. treated rTg4510 mice implicated the same sub-regional
structures as the ex vivo results, although these findings were
not as spatially extensive. Nevertheless, for mouse studies with
no prior knowledge regarding neurological alterations, these
in vivo results would be sufficient to guide further histological
evaluation into the underlying cellular changes underpinning the
MRI findings.
The ability of TBM to detect a local volumetric expansion
or contraction is dependent upon the standard deviation of
Jdet values in the groups at each voxel, WTstdev (or σpooled).
This variability is dependent upon the ability of the registration
algorithm to successfully align equivalent voxels, which itself
depends upon constraint parameters (in NiftyReg, bending
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energy and control point spacing) as well as on the inherent
image contrast of the brain structures. Low contrast regions
may register poorly: structures with relatively homogeneous
intensities have less information to inform registration. Here,
misalignments may arise, resulting in greater local WTstdev, and
hence a greater local effect size (or Narm) requirement in order
to achieve the desired power. This appears to be the case in
the midbrain and striatum of the in vivo group, where there is
lower structural contrast than ex vivo, and consequently, greater
Narm . Additionally, the variability in the cortex may be due to
misregistrations with external material on the surface of the skull;
a greater problem at lower resolutions, where the separation of
this material from the brain is less distinct.
Post-hoc tests can inform future studies. As the WTstdev and
WTmean vary between brain regions, the power of each test varies
and different sample size estimates are prescribed, throughout the
brain. Notably, around the ventricles, where structural variability
between animals was higher, sample size estimates were elevated.
In most brain regions, especially ex vivo, small group sizes appear
sufficient to differentiate groups. This is also dependent upon the
effect size chosen (here, 0.25 of a voxel). Smaller changes would
require greater Narm in each group. To obtain a useful sample
size for a future study focussing on a specific brain region (e.g.,
the hippocampus or cortex, in the rTg4510 mouse), it would
be advisable to use that region to set the N per study arm. The
group sizes in this study were sufficient to reveal significant group
differences throughout most of the brain.
CONCLUSION
In this work, we explored the compromises and trade-offs
between in vivo and ex vivo MRI in conjunction with TBM
for detecting regions of morphometric change in the rTg4510
mouse model. Our findings support the utility of in vivoMRI for
assessment of morphological changes in transgenic mice, where
atrophy was detected in equivocal regions to ex vivo imaging.
In addition, the in vivo data does not suffer from dehydration
or distortion artifacts, which may confound ex vivo studies. Our
TBV findings suggest that tissue shrinkage is similar in rTg4510
mice and WT controls, with relative preservation of key central
brain structures such as the cortex and hippocampus. The TBM
results also indicated that ex vivo MRI may offer increased
sensitivity to subtle morphological changes with the same sample
size, such as the response to a therapeutic intervention.
We hope that this work will help support and inform research
groups working in the field of preclinical MRI, and shape their
decision about the best way to image their transgenic mice.
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